Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Coetzee

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Cancer Causes & Control : CCC|September 13, 2001
Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States)S A Ingles, J Wang, G A Coetzee, et al.
Human Molecular Genetics|September 1, 1995
Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genesD C Rubinsztein, J Leggo, G A Coetzee, et al.
Human Genetics|December 1, 1991
Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areasF Graadt van Roggen, D R van der Westhuyzen, A D Marais, et al.
Cancer Research|March 8, 2000
Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen lociW Xue, R A Irvine, M C Yu, et al.
American Journal of Human Genetics|February 1, 1992
A nonsense mutation in the LDL receptor gene leads to familial hypercholesterolemia in the Druze sectD Landsberger, V Meiner, A Reshef, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, ChinaS J London, J M Yuan, G A Coetzee, et al.
Cancer Research|February 28, 2001
Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotypeR McKean-Cowdin, H S Feigelson, M C Pike, et al.
Cancer Research|February 24, 2001
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidatesH S Feigelson, R McKean-Cowdin, G A Coetzee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Genetic susceptibility to cancer from exogenous and endogenous exposuresH S Feigelson, R K Ross, M C Yu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetranceW J de Villiers, D R van der Westhuyzen, G A Coetzee, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Cancer Causes & Control : CCC|September 13, 2001
Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States)S A Ingles, J Wang, G A Coetzee, et al.
Human Molecular Genetics|September 1, 1995
Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genesD C Rubinsztein, J Leggo, G A Coetzee, et al.
Human Genetics|December 1, 1991
Low density lipoprotein receptor founder mutations in Afrikaner familial hypercholesterolaemic patients: a comparison of two geographical areasF Graadt van Roggen, D R van der Westhuyzen, A D Marais, et al.
Cancer Research|March 8, 2000
Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen lociW Xue, R A Irvine, M C Yu, et al.
American Journal of Human Genetics|February 1, 1992
A nonsense mutation in the LDL receptor gene leads to familial hypercholesterolemia in the Druze sectD Landsberger, V Meiner, A Reshef, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, ChinaS J London, J M Yuan, G A Coetzee, et al.
Cancer Research|February 28, 2001
Risk of endometrial cancer and estrogen replacement therapy history by CYP17 genotypeR McKean-Cowdin, H S Feigelson, M C Pike, et al.
Cancer Research|February 24, 2001
Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidatesH S Feigelson, R McKean-Cowdin, G A Coetzee, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Genetic susceptibility to cancer from exogenous and endogenous exposuresH S Feigelson, R K Ross, M C Yu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 1, 1997
The apolipoprotein E2 (Arg145Cys) mutation causes autosomal dominant type III hyperlipoproteinemia with incomplete penetranceW J de Villiers, D R van der Westhuyzen, G A Coetzee, et al.
Pageof 11